BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35664771)

  • 1. Concurrent Germline and Somatic Mutations in FLCN and Preliminary Exploration of Its Function: A Case Report.
    Wang T; Yang Y; Feng H; Cui B; Lv Z; Zhao W; Zhang X; Ma X
    Front Oncol; 2022; 12():877470. PubMed ID: 35664771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLCN: The causative gene for Birt-Hogg-Dubé syndrome.
    Schmidt LS; Linehan WM
    Gene; 2018 Jan; 640():28-42. PubMed ID: 28970150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.
    Schmidt LS; Linehan WM
    Expert Opin Orphan Drugs; 2015; 3(1):15-29. PubMed ID: 26581862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign clear cell "sugar" tumor of the lung in a patient with Birt-Hogg-Dubé syndrome: a case report.
    Gunji-Niitsu Y; Kumasaka T; Kitamura S; Hoshika Y; Hayashi T; Tokuda H; Morita R; Kobayashi E; Mitani K; Kikkawa M; Takahashi K; Seyama K
    BMC Med Genet; 2016 Nov; 17(1):85. PubMed ID: 27871249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer.
    Nahorski MS; Lim DH; Martin L; Gille JJ; McKay K; Rehal PK; Ploeger HM; van Steensel M; Tomlinson IP; Latif F; Menko FH; Maher ER
    J Med Genet; 2010 Jun; 47(6):385-90. PubMed ID: 20522427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon adenocarcinoma and Birt-Hogg-Dubé syndrome in a young patient: case report and exploration of pathologic implications.
    Jirka GW; Lefler DS; Russo J; Bashir B
    Cancer Biol Ther; 2023 Dec; 24(1):2184153. PubMed ID: 36859772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome.
    Kennedy JC; Khabibullin D; Boku Y; Shi W; Henske EP
    Semin Respir Crit Care Med; 2020 Apr; 41(2):247-255. PubMed ID: 32279295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birt-Hogg-Dubé syndrome in Korean: clinicoradiologic features and long term follow-up.
    Lee JH; Jeon MJ; Song JS; Chae EJ; Choi JH; Kim GH; Song JW
    Korean J Intern Med; 2019 Jul; 34(4):830-840. PubMed ID: 30360018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel germline mutations in FLCN gene identified in two Chinese patients with Birt-Hogg-Dubé syndrome.
    Li T; Ning X; He Q; Gong K
    Chin J Cancer; 2017 Jan; 36(1):4. PubMed ID: 28069055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Birt-Hogg-Dubé (BHD) Syndrome Harboring a Novel Folliculin (FLCN) Gene Mutation.
    Yukawa T; Fukazawa T; Yoshida M; Morita I; Kato K; Monobe Y; Furuya M; Naomoto Y
    Am J Case Rep; 2016 Oct; 17():788-792. PubMed ID: 27780965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.
    Schmidt LS; Linehan WM
    Nat Rev Urol; 2015 Oct; 12(10):558-69. PubMed ID: 26334087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A de novo FLCN mutation in a patient with spontaneous pneumothorax and renal cancer; a clinical and molecular evaluation.
    Menko FH; Johannesma PC; van Moorselaar RJ; Reinhard R; van Waesberghe JH; Thunnissen E; Houweling AC; Leter EM; Waisfisz Q; van Doorn MB; Starink TM; Postmus PE; Coull BJ; van Steensel MA; Gille JJ
    Fam Cancer; 2013 Sep; 12(3):373-9. PubMed ID: 23264078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic characteristics of Chinese patients with BHD syndrome and functional analysis of FLCN variants.
    Liu K; Xu W; Tian X; Xiao M; Zhao X; Zhang Q; Qu T; Song J; Liu Y; Xu KF; Zhang X
    Orphanet J Rare Dis; 2019 Oct; 14(1):223. PubMed ID: 31615547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
    Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
    Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report.
    Li J; Liu F; Liu X; Hu Y; Liu Z; Shen Y; Wan J
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2319-2325. PubMed ID: 36258004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birt-Hogg-Dubé syndrome: a literature review and case study of a Chinese woman presenting a novel FLCN mutation.
    Hao S; Long F; Sun F; Liu T; Li D; Jiang S
    BMC Pulm Med; 2017 Feb; 17(1):43. PubMed ID: 28222720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families.
    Houweling AC; Gijezen LM; Jonker MA; van Doorn MB; Oldenburg RA; van Spaendonck-Zwarts KY; Leter EM; van Os TA; van Grieken NC; Jaspars EH; de Jong MM; Bongers EM; Johannesma PC; Postmus PE; van Moorselaar RJ; van Waesberghe JH; Starink TM; van Steensel MA; Gille JJ; Menko FH
    Br J Cancer; 2011 Dec; 105(12):1912-9. PubMed ID: 22146830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birt-Hogg-Dubé syndrome in an Indonesian patient with folliculin gene mutation.
    Wiyono WH; Nurwidya F; Baskoro H; Putra AC
    Respirol Case Rep; 2016 Nov; 4(6):e00199. PubMed ID: 28031834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of
    Liu L; Yang K; Wang X; Shi Z; Yang Y; Yuan Y; Guo T; Xiao X; Luo H
    Biomed Res Int; 2017; 2017():8751384. PubMed ID: 28785590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
    Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.